March Biosciences
March Biosciences is a clinical-stage cell therapy company that focuses on developing CAR-T cell strategies to address hematological cancers.
- Founded
- 2021
- Headcount
- 16
- Open roles
- 0
- Last raised
- Grant · $200K
- Tech stack (March Biosciences engineering primaries)
- Hiring focus this quarter
- Interview format & rubric
- Comp bands by level
- Decision-makers in talent
- Recent news & moves
7-day free trial · $25/mo · cancel anytime
